Invention Grant
- Patent Title: 1,4-Oxazines useful as selective BACE1 inhibitors
-
Application No.: US16323827Application Date: 2017-08-18
-
Publication No.: US10399995B2Publication Date: 2019-09-03
- Inventor: Steven James Green , Erik James Hembre, II , Dustin James Mergott
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Nelsen L Lentz
- International Application: PCT/US2017/047554 WO 20170818
- International Announcement: WO2018/039062 WO 20180301
- Main IPC: C07D413/12
- IPC: C07D413/12 ; A61K31/5377 ; C07D513/04 ; A61P25/28
Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, useful as a BACE1 inhibitor.
Public/Granted literature
- US20190161502A1 1,4-OXAZINES USEFUL AS SELECTIVE BACE1 INHIBITORS Public/Granted day:2019-05-30
Information query
